chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He received his 1st dose of Pfizer (March 21,2021),2nd dose of Pfizer (April 21,2021) and his 3rd dose a Moderna vaccine last August 2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 1st dose of Pfizer (March 21,2021),2nd dose of Pfizer (April 21,2021) and his 3rd dose a Moderna vaccine last August 2021) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer-Biontech COVID-19 Vaccine (Dose 1 was administered in his Left arm) on 21-Mar-2021 and Pfizer-Biontech COVID-19 Vaccine (Dose 2 was administered in his Left arm) on 21-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer-Biontech COVID-19 Vaccine and Pfizer-Biontech COVID-19 Vaccine. Concurrent medical conditions included Ulcerative colitis since 1987, Allergy to antibiotic (experienced reaction with Amoxicillin.) and Allergy to antibiotic (and got sick with CIPRO). Concomitant products included MESALAMINE and MERCAPTOPURINE for an unknown indication.    In August 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 1st dose of Pfizer (March 21,2021),2nd dose of Pfizer (April 21,2021) and his 3rd dose a Moderna vaccine last August 2021). In August 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 1st dose of Pfizer (March 21,2021),2nd dose of Pfizer (April 21,2021) and his 3rd dose a Moderna vaccine last August 2021) had resolved.            Concomitant includes Curcumin with Bioterine 100mg one tablet per day  Treatment details were not given.   This case was linked to MOD-2022-476117 (Patient Link).
Within 20 minutes my arms were tingly, but that was short lived.  Later in the evening I got a nose bleed that coagulated right away.  First in my right nostril, and a couple hours later when laying Down for bed, in my left nostril.
Information had been received on 14-JUN-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a male patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 28-APR-2011 (Facility where inoculated was not reported; it was in same state of patients residence) as recommended for routine adult health maintenance for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of Herpes Zoster. While vacationing in (another state), the male patient broke out with a blistering vesicular rash and was treated at the emergency room. On or about 13-MAY-2013, the male patient followed up on his emergency treatment at a medical facility (in his state of residence). The male was treated by a physician, M.D., who diagnosed his condition as severe Herpes Zoster, or shingles.  On or about 20-MAR-2014, the male patient was treated again by the physician, M.D. (same physician as 13-MAY-2013) for worsening symptoms, at which time, the male patient was given the new diagnosis of post herpetic neuralgia.  The male patient has been prescribed Gabapentin and Acyclovir to help manage his painful symptoms.  As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Complete loss of cardiovascular fitness approximately one month following second vaccination shot. Racing heart beat not corresponding to physical activity. Shortness of breath not corresponding to physical activity. Exhaustion.
Nausea, headache, light headed, and fatigued. all in morning when first woke up at 6:30ish am. Lasted throughout the day until about 3 pm.
pt recvd vax;began having h/a on 8nov followed by pain in rt neck & shoulder; on 9nov had severe pain in the back &  legs w/ numbness in feet,toes & fingers;in ofc on 11nov w/ c/o numbness;pt referred to neurologist,poss dx of GBS;
Pt vaccinated with Engerix-B felt could faint, nauseated, running temp events started 14JUL90 at 11PM & lasted until 15JUL90 1PM.
This spontaneous report was received from a pharmacist via company representative refers to a 60 year old female patient. The patients medical history included shingles three months prior to the vaccination. On 03-JUL-2013, the patient was vaccinated with a dose of ZOSTAVAX, (lot # H019997), expiry date Feb 2014, route was subcutaneous). Concomitant medications were not reported. on 05-JUL-2013, the patients left arm was totally red after receiving ZOSTAVAX which was other than indicated in the prescribing information. The patient was prescribed Prednisone. The outcome of left arm was totally red was unknown. It was unspecified if patient sought medical attention. Additional information has been requested.
Information has been received from a registered nurse concerning a 12 year old male who on 05-SEP-2007 was vaccinated SC with a 0.65 ml of Zostavax (Oka/Merck) (Lot # 658211/0884U) instead of a dose of Varivax (Oka/Merck) (MSD). It was reported that the vials looks alike. No adverse event was reported. A product quality complaint was not involved. Additional information has been received from the registered nurse who stated the product confusion occurred because both the vaccine's vials looked alike and both were stored in the same freezer. There were no adverse symptoms. Additional information has been requested.
case tested positive on 1/1/22 at hospital . ventilated on 1/4. died 1/15
SEVERE REACTION TO PATIENTS UPPER ARM WHERE SHOT WAS GIVEN.  RED, SWOLLEN, HOT TO TOUCH, TENDER, AND HARD TO MOVE SHOULDER.
Information has been received from a 30 year old female consumer who is a pediatric ICU nurse with no known allergies who in 1/02, had a MMRII titer done and she was not immune to rubella, therefore, on 3/14/02 was vaccinated with a dose of MMRII (lot 636400/1276K). There was no concomitant medication. On the day of vaccination, her arm was sore. On 3/21/02, the pt experienced a high fever, raised rash all over the body and joint pain. On 3/22/02, she reported that "she is still feeling this now". Her doctor had her on Benadryl for the rash and itching and Tylenol for the pain. Her doctor feels that it "was a serum reaction". The pt reported that she "needs documentation that she called in for work and she is unable to return until her rash clears up". It was reported that the pt was vaccinated with the MMR vaccine in 12/72, mumps vaccine in 1975 and the 1st and 2nd dose of the rubella vaccine in 9/75 and 3/82, respectively. Additional info has been requested.  Received on 06/04/2003: "Follow-up information has been received from a registered nurse.  The nurse reported that the patient had allergies to iodine and shellfish (conflicting information).  On 03/20/2002, the patient developed fatigue, fever and chills, joint pain, headache, and an itchy, fine papular rash over her whole body.  On 03/21/2002, the patient was "feeling batter."  The patient was treated with ibuprofen and diphenhydramine (BENADRYL).  On 03/25/2002, the patient's rash and fever resolved.  No additional information is expected.
Initial report was received from another manufacturer on 23 January 2012 (Services Request Number 1-4810764278). A female patient (age not reported) had received an influenza vaccine (manufacturer, lot number, date site and route of administration not reported) 20 years ago and an unspecified amount of time later developed chronic inflammatory polyneuropathy. Past medical history and concomitant medications were not reported. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
(L) upper arm red, warm, swollen shoulder to elbow - non tender Nl ROM of arm.
This report is regarding the Pfizer COVID-19 vaccination the patient  received on the above date, which was lot number FD0809. Public Health, per guidance from the Department of Health, Centers for Disease Control and Preventio (CDC), and Pfizer have determined that the dose of vaccine that the patient received is valid.
I had a really bad headache on Monday morning, I had a fever 100.5, I went to Urgent care. I knew that morning when I ate a banana I could not taste that I had covid. I had body aches, loss of taste and smell. I was drenched and sweat at night. I was also congested and a little short of breath I was able to get in have the monoclonal antibodies, I'm on my 10th day and I haven't had a fever for 24 hours and I'm still very fatigued and loss of taste and smell have not returned.
The patient was given the Pfizer COVID vaccine. The patient immediately felt nausea and dizzy. The patient's wife asked up to call for help and we called 9-1-1. The patient then fainted and had some seizure like activity. The patient woke up immediately after. The patient had no previous history of fainting or seizures but has almost fainted after blood tests. The EMT's came and checked his vitals which were all normal. Then the patient was taken to the hospital.
having a lot of side effect/This is useless and frustrating; having a lot of side effect/This is useless and frustrating; This is a spontaneous report from a contactable consumer (patient, reported for self).   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported; Expiration date: UNKNOWN), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation (reason for no lot number: of COVID-19 vaccine: Complainant hung up abruptly/transfer incomplete). The patient medical history and concomitant medications were not reported.   The reporter (patient) stated, "I am having a lot of side effect (Further not clarified hence captured verbatim) from Pfizer vaccine (Confirmed as Pfizer COVID-19 vaccine) and nobody seems to know how to resolve it, I have been given this information by my pharmacist and I am just trying to figure out who I should contact to, communicate my side effect."  When paraphrased the concern, reporter stated, "Yeah, I been having it from 2 months. Yeah, I would like to is there anyway to resolve it." Reporter stated that this is useless and frustrating, nothing help its all useless. Product details and pharmacy details could not be probed as the consumer hung up abruptly. Hence limited information available. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Approximately 14:05 patient reported feeling itchy all over body. patient scratching arms and chest, redness at scratching sites. Breathing regular rate and rhythm. Denies shortness of breath, throat tightness, angioedema, palpitations, nausea, chest or abd pain. patient states similar symptom with previous Moderna vaccine, did not require medical intervention, she went home and took allergy medication and itchiness resolved shortly after. patient states she lives less than 5 mins away from clinic.  ***   14:06 TC to supervising provider.  VVO for diphenhydramine 25 mg PO, have patient wait at least another 15 mins or until symptoms start to resolve.  ***   14:08 Administered diphenhydramine 25 mg PO.  ***   14:11 BP 153/87, HR 76, O2Sat 97% room air, RR 18.  ***   14:20 BP 143/78, HR 78, O2Sat 99% room air, RR 18.  patient states symptoms resolving.  ***   14:25 patient states symptoms have resolved, no longer scratching. Reviewed s/s to call 911, seek immediate medical attention: shortness of breathe, difficulty breathing, angioedema, chest/throat tightness. patient verbalized understanding.  ***
I had mild reaction next day12/31/20, sore, some swelling and warm. 2 days later that was gone - on 1/8/2021 I woke up with a 2x2 rash, itchiness and warm , some swelling -
10 Days after the injection the left are is extremely red , swollen , fevered and itches.  Both feet are experience extreme nuropothy pain in the toe next to the big toe and feel as though the blood flow is restricted.
After first dose I started to experience tingling in my wrists and hands.  This started two days after the first dose.  After the second dose I experienced tingling now in both my feet and hands.  The intensity greatly increased with the second dose.  Along with the tingling, my feet was now painful, both while walking or sitting.  The tingling started to spread to my lower legs, just above the ankles. These sensations lasted two and a half months.  They are now gone.
fainting upon rising; tingling in the base of the brain, face, and either one or both sides of brain/over tingling in the brain/a low throbbing mild headache/moderate to severe headache; increased blood pressure; shooting pain from shot site to right ear; no increase in weight; shooting pain from shot site to right ear; feeling like something is crawling up neck or down the back; tingling in the base of the brain, face, and either one or both sides of brain/over tingling in the brain/a low throbbing mild headache/moderate to severe headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "a life of low blood pressure for over 50 years" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization; Bnt162b2 (Dose: 3), for COVID-19 immunization. The following information was reported: SYNCOPE (medically significant), outcome "unknown", described as "fainting upon rising"; HEADACHE (non-serious), PARAESTHESIA (non-serious), outcome "unknown" and all described as "tingling in the base of the brain, face, and either one or both sides of brain/over tingling in the brain/a low throbbing mild headache/moderate to severe headache"; BLOOD PRESSURE INCREASED (non-serious), outcome "unknown", described as "increased blood pressure"; VACCINATION SITE PAIN (non-serious), EAR PAIN (non-serious), outcome "unknown" and all described as "shooting pain from shot site to right ear"; WEIGHT GAIN POOR (non-serious), outcome "unknown", described as "no increase in weight"; FORMICATION (non-serious), outcome "unknown", described as "feeling like something is crawling up neck or down the back". The patient underwent the following laboratory tests and procedures: Blood pressure measurement: increased, notes: Increased blood pressure; SARS-CoV-2 test: Positive, notes: The first time I felt this initial tingling was for several days during a positive COVID test (31Dec2020 through 19Jan2021).  Clinical course: Patient's symptoms included tingling in the base of the brain, face, and either one or both sides of brain. It returned recently with patients second booster (4th total) Pfizer vaccine shot. Other symptoms were increased blood pressure from a life of low blood pressure for over 50 years to the point of fainting upon rising, to borderline high blood pressure. Patient received timely vaccines when offered. Patient continued to work in the public arena throughout the pandemic, going into homes and courts and currently admission Clinician at (Facility Name Withheld). Patient's hope was to be a part of studies to find out what is going on and to seek solutions.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On the 8th noticed that I was starting to break out in what I thought was zits. 06/10/11 First urgent care visit: diag with staph infection for pustules covering neck, back and chest. Given bactroban and told to return if spread or fever. That night had fever of 100 and chills, was spreading to groin and legs. On 06/12 went back to facility and recieved Dioxycylcen. Worked a little then they returned. Finally saw a derm and diag with pseudo folliculitis, but not been in hot tub, or pool! They gave me a weeks worth of Ketoconazole and it mostly cleared, while leaving brown, scarring spots. Wrote another 2 weeks worth of Ketoconazole (oral) and just about cleared then the itch started so the derm gave a shot of anti-infl/steroid in the gluts. Within two days I am red free and so far no more pustules.
Shoulder pain after getting the 1st dose of the Pfizer Covid-19 Vaccine; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer reporting himself. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), dose 1 via an unspecified route of administration on 04Feb2021 as 1ST DOSE, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced shoulder pain after getting the 1st dose of the Pfizer COVID-19 vaccine on an unspecified date. Clinical outcome for event was unknown.  Information about Batch/Lot number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
WILL BE ON HEART MEDS THE REST OF LIFE; This spontaneous report received from a parent concerned a 33 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was in an organization so was healthy till the vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 29-NOV-2021, the patient experienced will be on heart meds the rest of life. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of will be on heart meds the rest of life was not reported. This report was non-serious.
pt recv vax 6JAN97 & next lt arm hot & achy;1/8 entire arm sore & edematous;could not close fist;watch band left indentations;9JAN97 edema gone but joints in lt arm & hand sore;still sore & knuckles swollen;
Small round welt beside vaccine administration site and leg red around welt and vaccine injection site on both legs.
Low grade fever- temp unknown, mild delirium, weakness in whole body, weakness when standing/walking, extreme soreness in upper arm into shoulder, fatigue after sleeping.
"1423 History of present illness-patient is a 47-year-old female with a significant past medical history presenting to the emergency department with large reaction. Patient received the Pfizer colored vaccination approximately 45 minutes prior to ED arrival. Patient had hives, throat swelling. EpiPen and Benadryl were administered. Patient has had significant improvement in her symptoms. Currently note throat swelling or shortness of breath. Hives markedly improved.  [SM]  1425 Medical decision making-47-year-old female presenting to the emergency department with allergic reaction. Likely anaphylaxis given airway involvement. Covid vaccination was likely trigger. Will administer Pepcid and prednisone.  [SM]  1426 Patient has been improving throughout the 2-hour ED stay. Will discharge with prescription for prednisone as well as EpiPen. Patient instructed to follow-up with PMD. She expresses a full understanding of the plan and is amenable to it. Strict return precautions given. All questions answered.  "
A non-serious spontaneous report of inadvertent administration of expired FluMist was received from a nurse concerning a patient of unknown age in a pediatricians office.  This case is submitted in accordance with manufacturer's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FluMist.  There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable and the event is considered resolved. Follow-up received 07-Oct-2000. No adverse event had been reported. Based on the results of the investigation, the root cause for the medication were caused by 1) customer not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that occuured shortly after teh product expired. Follow-up received 30-Mar-2000: added product complaint investigation results.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2014, a healthcare provider administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity, and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Patient received Prevnar 20 08/10/2023. Patient came back to clinic 08/14/2023 with the right arm red and swollen. Patinet was afebrile. Patient was counseled on the signs and symptoms to monitor, was given a cold compress for the arm, and was advised to take Tylenol for pain.
Information has been received from a physician concerning a 12 year old female with no pertinent medical history, known allergies or drug reactions, who on 18-AUG-2008 was vaccinated with a first dose of GARDASIL (lot no. 660553/0070X) 0.5 ml, IM.  Concomitant therapy included BOOSTRIX.  In August 2008, after vaccination, the patient experienced flu-like symptoms, nausea and vomiting.  Subsequently, the patient recovered the symptoms.  A urinalysis was performed (no results available).  The patient was seen by the physician.  Additional information has been requested.
Bilateral tinnitus. I have periodically noticed tinnitus throughout my life, but it has been persistent over the past few months. It won't necessarily wake me up, but if I wake up in the middle of the night, it has a tendency to keep me up.  It is less noticeable with white noise or some other ambient sound(s) and doesn't necessarily seem to affect my hearing.